Market By Products, Applications, End-users And Geography | Forecast 2019-2027
The North America immunohistochemistry market is expected to display an upward trend by exhibiting a CAGR of 7.19% over the forecast years of 2019-2027.
Countries covered in the North America immunohistochemistry market are:
• The United States
• Canada
To get detailed insights on segments, Download Sample Report
Autoimmune disease is one of the topmost reasons for death in the region, mainly among the young girls along with women belonging to all age groups up to the age of 64 years. According to the National Institute of Health (NIH), 23.5 million of the American population has been impacted by autoimmune diseases as compared to cancer that impacted around 9 million Americans and heart diseases that impacted up to 22 million in the year 2016. The NIH research plan considering autoimmune disease states research discoveries of the past decade have made the autoimmune research as one of the key areas of new discovery.
The immunohistochemistry market in Canada is expected to be on the upsurging trend due to the prevalence of cancer in the country. The occurrence of cancer in Canada is widespread, making it one of the leading nations with a large number of cancer cases in North America. This report includes detailed information about the history of immunohistochemistry, the value chain outlook, Porter’s five force analysis, the market attractiveness matrix, vendor scorecard, key impact analysis, industrial player positioning and the key market strategies.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA IMMUNOHISTOCHEMISTRY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. HISTORY
OF IMMUNOHISTOCHEMISTRY
2.2. VALUE
CHAIN OUTLOOK
2.3. KEY
INSIGHTS
2.4. REGULATORY
OUTLOOK
2.4.1. REGULATIONS
IN THE UNITED STATES
2.5. MARKET
ATTRACTIVENESS MATRIX
2.6. MARKET
DRIVERS
2.6.1. IN-VITRO
TECHNOLOGICAL ADVANCEMENTS
2.6.2. INCREASING
CANCER OCCURRENCE
2.6.3. SWELLING
HEALTHCARE SPENDING
2.6.4. RISING
GERIATRIC POPULATION
2.6.5. INCREASING
USE OF POC TESTING
2.7. MARKET
RESTRAINTS
2.7.1. RESTRICTIONS
OF CLOSED SYSTEMS
2.7.2. REIMBURSEMENT
ISSUES
2.8. MARKET
OPPORTUNITIES
2.8.1. INCREASING
USE OF BIOMARKERS FOR DISEASE DIAGNOSIS
2.8.2. TECHNOLOGICAL
ADVANCEMENTS
2.9. MARKET
CHALLENGES
2.9.1. STRINGENT
REGULATIONS
2.9.2. HIGH
MAINTENANCE COST INFLUENCING THE MARKET GROWTH
3. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY PRODUCTS
3.1. ANTIBODIES
3.1.1. PRIMARY
ANTIBODIES
3.1.2. SECONDARY
ANTIBODIES
3.2. EQUIPMENT
3.2.1. SLIDE
STAINING SYSTEMS
3.2.2. TISSUE
MICROARRAYS
3.2.3. TISSUE
PROCESSING SYSTEMS
3.2.4. SLIDE
SCANNERS
3.2.5. OTHER
EQUIPMENT
3.3. REAGENTS
3.3.1. HISTOLOGICAL
STAINS
3.3.2. BLOCKING
SERA AND REAGENTS
3.3.3. CHROMOGENIC
SUBSTRATES
3.3.4. FIXATION
REAGENTS
3.3.5. STABILIZERS
3.3.6. ORGANIC
SOLVENTS
3.3.7. PROTEOLYTIC
ENZYMES
3.3.8. DILUENTS
3.4. KITS
4. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY APPLICATIONS
4.1. DIAGNOSTICS
4.1.1. CANCER
4.1.2. INFECTIOUS
DISEASES
4.1.3. CARDIOVASCULAR
DISEASE
4.1.4. AUTOIMMUNE
DISEASES
4.1.5. DIABETES
MELLITUS
4.1.6. NEPHROLOGICAL
DISEASES
4.2. DRUG
TESTING
5. IMMUNOHISTOCHEMISTRY
(IHC) MARKET OUTLOOK - BY END-USERS
5.1. HOSPITALS
AND DIAGNOSTIC LABORATORIES
5.2. RESEARCH
INSTITUTES
5.3. OTHER
END-USERS
6. IMMUNOHISTOCHEMISTRY
(IHC) MARKET - NORTH AMERICA
6.1. COUNTRY
ANALYSIS
6.1.1. THE
UNITED STATES
6.1.2. CANADA
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. ABCAM
PLC
7.3. AGILENT
TECHNOLOGIES, INC.
7.4. BIOGENEX
7.5. BIO-RAD
LABORATORIES, INC.
7.6. BIO
SB
7.7. CELL
SIGNALING TECHNOLOGY, INC.
7.8. DANAHER
CORPORATION
7.9. F.
HOFFMANN-LA ROCHE AG
7.10.
HISTOLOGIX
7.11.
MERCK MILLIPORE
7.12.
PERKINELMER, INC.
7.13.
SIEMENS AG HEALTHCARE
7.14.
THERMO FISHER SCIENTIFIC, INC.
8. METHODOLOGY
AND SCOPE
8.1. RESEARCH
SCOPE
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1 NORTH AMERICA MARKET FOR
IMMUNOHISTOCHEMISTRY BY REGION 2019-2027 ($ MILLION)
TABLE 2 CANCER MARKERS USED IN DIAGNOSIS AND
TREATMENT
TABLE 3 NORTH AMERICA IMMUNOHISTOCHEMISTRY
MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 4 NORTH AMERICA IMMUNOHISTOCHEMISTRY
MARKET IN ANTIBODIES BY TYPE 2019-2027 ($ MILLION)
TABLE 5 CLINICALLY IMPORTANT MONOCLONAL
ANTIBODIES
TABLE 6 SECONDARY ANTIBODY SELECTIONS
TABLE 7 NORTH AMERICA IMMUNOHISTOCHEMISTRY
MARKET IN EQUIPMENT BY TYPES 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA IMMUNOHISTOCHEMISTRY
MARKET IN REAGENTS BY TYPE 2019-2027 ($ MILLION)
TABLE 9 HISTOLOGY STAINS AND ITS CATEGORIES
TABLE 10 COMMON FIXATIVES AND THEIR GENERAL TARGET
ANTIGENS
TABLE 11 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET
IN KITS 2019-2027 ($ MILLION)
TABLE 12 KIT COMPONENTS ARE AVAILABLE FOR IHC
OPTIMIZATION
TABLE 13 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET
BY APPLICATION 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET
IN DIAGNOSTICS BY TYPE 2019-2027 ($ MILLION)
TABLE 15 SELECTED INFECTIOUS ETIOLOGIES OF
AUTOIMMUNE DISEASES
TABLE 16 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET
BY END-USERS 2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET
BY COUNTRY 2019-2027 ($ MILLION)
FIGURE 1 NORTH AMERICA MARKET FOR
IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)
FIGURE 2 HISTORY OF IMMUNOHISTOCHEMISTRY
FIGURE 3 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET
IN ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA ANTIBODIES MARKET IN PRIMARY
ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA ANTIBODIES MARKET IN
SECONDARY ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET
IN EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 7 NORTH AMERICA EQUIPMENT MARKET IN SLIDE
STAINING SYSTEMS 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA EQUIPMENT MARKET IN TISSUE
MICROARRAYS 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA EQUIPMENT MARKET IN TISSUE PROCESSING
SYSTEMS 2019-2027 ($ MILLION)
FIGURE 10 NORTH AMERICA EQUIPMENT MARKET IN SLIDE
SCANNERS 2019-2027 ($ MILLION)
FIGURE 11 NORTH AMERICA EQUIPMENT MARKET IN OTHER
EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN
REAGENTS 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA REAGENTS MARKET IN HISTOLOGICAL
STAINS 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA REAGENTS MARKET IN BLOCKING
SERA AND REAGENTS 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA REAGENTS MARKET IN CHROMOGENIC
SUBSTRATES 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA REAGENTS MARKET IN FIXATION
REAGENTS 2019-2027 ($ MILLION)
FIGURE 17 NORTH AMERICA REAGENTS MARKET IN STABILIZERS
2019-2027 ($ MILLION)
FIGURE 18 NORTH AMERICA REAGENTS MARKET IN ORGANIC SOLVENTS
2019-2027 ($ MILLION)
FIGURE 19 NORTH AMERICA REAGENTS MARKET IN PROTEOLYTIC
ENZYMES 2019-2027 ($ MILLION)
FIGURE 20 NORTH AMERICA REAGENTS MARKET IN DILUENTS
2019-2027 ($ MILLION)
FIGURE 21 PHASES OF HISTOLOGICAL STAINING
FIGURE 22 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN
KITS 2019-2027 ($ MILLION)
FIGURE 23 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS
2019-2027 ($ MILLION)
FIGURE 24 NORTH AMERICA DIAGNOSTICS MARKET IN CANCER
2019-2027 ($ MILLION)
FIGURE 25 NORTH AMERICA DIAGNOSTICS MARKET IN
INFECTIOUS DISEASES 2019-2027 ($ MILLION)
FIGURE 26 NORTH AMERICA DIAGNOSTICS MARKET IN
CARDIOVASCULAR DISEASE 2019-2027 ($ MILLION)
FIGURE 27 NORTH AMERICA DIAGNOSTICS MARKET IN
AUTOIMMUNE DISEASES 2019-2027 ($ MILLION)
FIGURE 28 NORTH AMERICA DIAGNOSTICS MARKET IN DIABETES
MELLITUS 2019-2027 ($ MILLION)
FIGURE 29 NORTH AMERICA DIAGNOSTICS MARKET IN
NEPHROLOGICAL DISEASES 2019-2027 ($ MILLION)
FIGURE 30 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN
DRUG TESTING 2019-2027 ($ MILLION)
FIGURE 31 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN
HOSPITALS AND DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)
FIGURE 32 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN
RESEARCH INSTITUTES 2019-2027 ($ MILLION)
FIGURE 33 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN
OTHER END-USERS 2019-2027 ($ MILLION)
FIGURE 34 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 35 THE UNITED STATES IMMUNOHISTOCHEMISTRY MARKET
2019-2027 ($ MILLION)
FIGURE 36 CANADA IMMUNOHISTOCHEMISTRY MARKET 2019-2027
($ MILLION)